Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

Published:2011-05-15 Issue:8 Volume:25 Page:1057-1064
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

McGowan Ian,Gomez Kailazarid,Bruder Karen,Febo Irma,Chen Beatrice A,Richardson Barbra A,Husnik Marla,Livant Edward,Price Clare,Jacobson Cindy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference14 articles.

1. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey;Pettifor;AIDS,2005

2. Microbicides for HIV prevention: reality or hope?;McGowan;Curr Opin Infect Dis,2010

3. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women;Abdool;Science,2010

4. Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention;McCarthy;Mol Pharm,2005

5. Structure activity relationship of dendrimer microbicides with dual action antiviral activity.;Tyssen;PLoS One,2010

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update zur bakteriellen Vaginose;Die Gynäkologie;2024-04-29

2. Bacterial Vaginosis: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/028, June 2023);Geburtshilfe und Frauenheilkunde;2023-11

3. Functionalizing Dendrimers for Targeted Delivery of Bioactive Molecules to Macrophages: A Potential Treatment for Mycobacterium tuberculosis Infection—A Review;Pharmaceuticals;2023-10-09

4. Nasal delivery as a strategy for the prevention and treatment of COVID-19;Expert Opinion on Drug Delivery;2023-08-03

5. Emerging Trends and Potential Prospects in Vaginal Drug Delivery;Current Drug Delivery;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3